UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.540

Sortiert nach

Quantitative PCR for Epstein–Barr virus DNA and RNA in multiple sclerosis

Multiple sclerosis, 2009-02, Vol.15 (2), p.153-158

2009

Volltextzugriff (PDF)

PCR for bacterial 16S ribosomal DNA in multiple sclerosis cerebrospinal fluid

Multiple sclerosis, 2008-03, Vol.14 (2), p.147-152

2008

Volltextzugriff (PDF)

P.010 Safety and efficacy of inebilizumab in AQP4+ NMOSD participants with history of immunosuppression treatment prior to N-MOmentum study

Canadian journal of neurological sciences, 2024-06, Vol.51 (s1), p.S17-S17

2024

Volltextzugriff (PDF)

P.009 Long-term comparative efficacy of inebilizumab from N-MOmentum participants versus azathioprine and immunosuppressants and placebo in NMOSD patients

Canadian journal of neurological sciences, 2024-06, Vol.51 (s1), p.S16-S17

2024

Volltextzugriff (PDF)

Ingested IFN-alpha: results of a pilot study in relapsing-remitting MS

Neurology, 2001-09, Vol.57 (5), p.845

2001

Volltextzugriff (PDF)

The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics

Multiple sclerosis and related disorders, 2012-04, Vol.1 (2), p.81-86

2012

Volltextzugriff (PDF)

Recurrent transverse myelitis, myasthenia gravis, and autoantibodies

Annals of neurology, 1992-09, Vol.32 (3), p.407-409

1992

Volltextzugriff (PDF)

Combination therapy with glatiramer acetate (copolymer-1) and a type I interferon (IFN-α) does not improve experimental autoimmune encephalomyelitis

Annals of neurology, 2000-01, Vol.47 (1), p.127-131

2000

Volltextzugriff (PDF)

Role of monkey midbrain near-response neurons in phoria adaptation

Journal of neurophysiology, 1992-06, Vol.67 (6), p.1475-1492

1992

Volltextzugriff (PDF)

Trimethylolpropane phosphate (TMPP) perfusion into the nucleus accumbens of the rat : Electroencephalographic, behavioral and neurochemical correlates

Neurotoxicology (Park Forest South), 1998-04, Vol.19 (2), p.215-225

1998

Volltextzugriff (PDF)

ACUTE EFFECTS OF A BICYCLOPHOSPHATE NEUROCONVULSANT ON MONOAMINE NEUROTRANSMITTER AND METABOLITE LEVELS IN THE RAT BRAIN

Journal of Toxicology and Environmental Health, Part A, 1998-07, Vol.54 (5), p.421-429

1998

Volltextzugriff (PDF)

Tissue distribution, metabolism, and clearance of the convulsant trimethylolpropane phosphate in rats

Drug metabolism and disposition, 1998-11, Vol.26 (11), p.1058

1998

Volltextzugriff (PDF)

T cell-T cell activation in multiple sclerosis

Multiple sclerosis, 1997-08, Vol.3 (4), p.238-242

1997

Volltextzugriff (PDF)

Perspectives on the U.S.-Mexico Soccer Rivalry: Passion and Politics in Red, White, Blue, and Green

1st ed. 2017 edition., 2017

Volltextzugriff (PDF)

Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosis

Neurology, 2008-07, Vol.71 (1), p.35

2008

Volltextzugriff (PDF)

Lack of response to rituximab therapy in patients with neuromyelitis optica: Response to Kim and Kim

Journal of the neurological sciences, 2012-08, Vol.319 (1), p.172-172

2012

Volltextzugriff (PDF)

Measuring the cellular immune response against Epstein-Barr virus in multiple sclerosis

Multiple sclerosis, 2008-09, Vol.14, p.S230-S230

2008

Volltextzugriff (PDF)

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

Multiple sclerosis, 2000-04, Vol.6 (4), p.255-266

2000

Volltextzugriff (PDF)

Multiple sclerosis: clinical presentation, diagnosis and treatment

American family physician, 1996-09, Vol.54 (4), p.1301

1996

Volltextzugriff (PDF)

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the I5-year analysis of the US prospective open-label study of glatiramer acetate

Multiple sclerosis, 2010, Vol.16 (3), p.342-350

2010

Volltextzugriff (PDF)

United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates

Multiple sclerosis, 2001-02, Vol.7 (1), p.33-41

2001

Volltextzugriff (PDF)

Review: PCR for bacterial 16S ribosomal DNA in multiple sclerosis cerebrospinal fluid

Multiple Sclerosis Journal, 2008-03, Vol.14 (2), p.147-152

2008

Volltextzugriff (PDF)

Familial recurrence rates and genetic models of multiple sclerosis

American journal of medical genetics. Part A, 2005-05, Vol.135A (1), p.53-58

Lindsey, J. William

2005

Volltextzugriff (PDF)

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Multiple sclerosis, 2008-09, Vol.14, p.S41-S41

2008

Volltextzugriff (PDF)

From treatment of experimental allergic encephalomyelitis to clinical trials in multiple sclerosis

Immunology series, 1993, Vol.59, p.253

1993

Volltextzugriff (PDF)

1 – 25 von 1.540

Suche als RSS-Feed

Aktive Filter

SpracheSpanisch

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.362)
Mit Volltextzugriff
(1.364)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.003)
Life Sciences & Biomedicine
(755)
Humans
(392)
Animals
(198)
Physical Sciences
(185)
Biological And Medical Sciences
(184)
Medical Sciences
(124)
Male
(90)
Technology
(85)
Chemistry
(84)
Social Sciences
(82)
Biochemistry & Molecular Biology
(80)
Fundamental And Applied Biological Sciences. Psychology
(76)
Surgery
(68)
Mice
(63)
Physics
(60)
Adult
(57)
Science & Technology - Other Topics
(57)
Environmental Sciences & Ecology
(56)
Microbiology
(56)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(24)
... seit 30 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Quantitative PCR for Epstein–Barr virus DNA and RNA in multiple sclerosis

PCR for bacterial 16S ribosomal DNA in multiple sclerosis cerebrospinal fluid

P.010 Safety and efficacy of inebilizumab in AQP4+ NMOSD participants with history of immunosuppression treatment prior to N-MOmentum study

P.009 Long-term comparative efficacy of inebilizumab from N-MOmentum participants versus azathioprine and immunosuppressants and placebo in NMOSD patients

Ingested IFN-alpha: results of a pilot study in relapsing-remitting MS

The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics

Recurrent transverse myelitis, myasthenia gravis, and autoantibodies

Combination therapy with glatiramer acetate (copolymer-1) and a type I interferon (IFN-α) does not improve experimental autoimmune encephalomyelitis

Role of monkey midbrain near-response neurons in phoria adaptation

Trimethylolpropane phosphate (TMPP) perfusion into the nucleus accumbens of the rat : Electroencephalographic, behavioral and neurochemical correlates

ACUTE EFFECTS OF A BICYCLOPHOSPHATE NEUROCONVULSANT ON MONOAMINE NEUROTRANSMITTER AND METABOLITE LEVELS IN THE RAT BRAIN

Tissue distribution, metabolism, and clearance of the convulsant trimethylolpropane phosphate in rats

T cell-T cell activation in multiple sclerosis

Perspectives on the U.S.-Mexico Soccer Rivalry: Passion and Politics in Red, White, Blue, and Green

Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosis

Lack of response to rituximab therapy in patients with neuromyelitis optica: Response to Kim and Kim

Measuring the cellular immune response against Epstein-Barr virus in multiple sclerosis

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

Multiple sclerosis: clinical presentation, diagnosis and treatment

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the I5-year analysis of the US prospective open-label study of glatiramer acetate

United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates

Review: PCR for bacterial 16S ribosomal DNA in multiple sclerosis cerebrospinal fluid

Familial recurrence rates and genetic models of multiple sclerosis

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

From treatment of experimental allergic encephalomyelitis to clinical trials in multiple sclerosis

Aktive Filter

Suchergebnisse filtern